Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 11, 2025

Primary Completion Date

March 27, 2028

Study Completion Date

May 8, 2028

Conditions

Bullous Pemphigoid (BP)

Interventions

BIOLOGICAL

Stapokibart injection

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Trial Locations (1)

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Chengdu Kangnuoxing Biopharma,Inc.

INDUSTRY